Okay, wow thank you!
I think there is clearly more to the story with CF33 / Vaxinia - Then a potent tool that can be used to treat all solid tumours.
Time will tell on the MAST study, but this adds to my concern CF 33 is struggling to get the job done on TNBC.
The other concern I have with the MAST study is the IT mono therapy cohort appears to be powering ahead. But the combination cohorts appear to no longer be progressing or albeit slowed right down. (The 4 cohorts were originally progressing lock at step with each dose escalation).
IT mono is now cleared for 1 X 10 to the 9
IT combination is still dosing in 3 X 10 to the 7
I think the gap is reaching a point where the company sould tell us what they are seeing in combination and why recruitment has slowed.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Okay, wow thank you!I think there is clearly more to the story...
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $424.5M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.7¢ | $279.1K | 4.840M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 244997 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 334668 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 1942028 | 0.056 |
36 | 2457603 | 0.055 |
10 | 1202174 | 0.054 |
10 | 624310 | 0.053 |
7 | 456430 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 267974 | 6 |
0.058 | 1087728 | 6 |
0.059 | 163000 | 2 |
0.060 | 501000 | 4 |
0.061 | 435830 | 6 |
Last trade - 10.15am 14/06/2024 (20 minute delay) ? |
|
|||||
Last
5.7¢ |
  |
Change
-0.001 ( 1.89 %) |
|||
Open | High | Low | Volume | ||
5.8¢ | 5.8¢ | 5.7¢ | 1242610 | ||
Last updated 10.29am 14/06/2024 ? |
Featured News
IMU (ASX) Chart |